Concepts (178)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Renal Insufficiency, Chronic | 9 | 2024 | 146 | 2.470 |
Why?
|
| Exercise | 15 | 2025 | 967 | 2.220 |
Why?
|
| Amylose | 2 | 2024 | 8 | 1.530 |
Why?
|
| Exercise Therapy | 8 | 2023 | 102 | 1.140 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2024 | 263 | 1.110 |
Why?
|
| Resistance Training | 3 | 2012 | 22 | 1.040 |
Why?
|
| Starch | 1 | 2024 | 87 | 0.800 |
Why?
|
| Kidney Failure, Chronic | 3 | 2020 | 197 | 0.780 |
Why?
|
| Blood Pressure | 4 | 2019 | 535 | 0.750 |
Why?
|
| Testosterone | 2 | 2012 | 128 | 0.660 |
Why?
|
| Cardiac Rehabilitation | 5 | 2023 | 76 | 0.630 |
Why?
|
| Weight Lifting | 3 | 2012 | 13 | 0.610 |
Why?
|
| Physical Exertion | 3 | 2025 | 81 | 0.600 |
Why?
|
| Occupations | 1 | 2018 | 52 | 0.550 |
Why?
|
| Heart Rate | 5 | 2023 | 334 | 0.550 |
Why?
|
| Oxygen Consumption | 4 | 2022 | 213 | 0.550 |
Why?
|
| Universities | 1 | 2018 | 169 | 0.510 |
Why?
|
| Oxidative Stress | 5 | 2024 | 322 | 0.510 |
Why?
|
| Caloric Restriction | 3 | 2021 | 21 | 0.470 |
Why?
|
| Sports Medicine | 2 | 2025 | 28 | 0.450 |
Why?
|
| Vascular Stiffness | 2 | 2014 | 17 | 0.440 |
Why?
|
| Middle Aged | 22 | 2024 | 18383 | 0.430 |
Why?
|
| Exercise Test | 4 | 2023 | 257 | 0.420 |
Why?
|
| Vascular Resistance | 1 | 2014 | 47 | 0.420 |
Why?
|
| Terminology as Topic | 2 | 2025 | 144 | 0.410 |
Why?
|
| Body Composition | 3 | 2012 | 155 | 0.410 |
Why?
|
| Metabolic Syndrome | 2 | 2012 | 146 | 0.400 |
Why?
|
| Hypotension | 2 | 2017 | 51 | 0.400 |
Why?
|
| Adult | 18 | 2024 | 17457 | 0.380 |
Why?
|
| Biomarkers | 6 | 2024 | 1483 | 0.380 |
Why?
|
| Aged | 16 | 2024 | 15048 | 0.380 |
Why?
|
| Lower Extremity | 2 | 2012 | 160 | 0.370 |
Why?
|
| Time Factors | 10 | 2021 | 3774 | 0.360 |
Why?
|
| Diet, Carbohydrate-Restricted | 1 | 2012 | 10 | 0.360 |
Why?
|
| Diet, Fat-Restricted | 1 | 2012 | 34 | 0.360 |
Why?
|
| Double-Blind Method | 3 | 2024 | 743 | 0.340 |
Why?
|
| Male | 23 | 2024 | 31177 | 0.330 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2017 | 732 | 0.320 |
Why?
|
| Humans | 33 | 2025 | 65452 | 0.320 |
Why?
|
| Cardiovascular Diseases | 1 | 2017 | 867 | 0.300 |
Why?
|
| Overweight | 1 | 2012 | 257 | 0.300 |
Why?
|
| Weight Loss | 1 | 2012 | 276 | 0.300 |
Why?
|
| Muscle, Skeletal | 2 | 2012 | 787 | 0.270 |
Why?
|
| Workplace | 2 | 2019 | 177 | 0.260 |
Why?
|
| Occupational Health | 2 | 2019 | 195 | 0.250 |
Why?
|
| Kidney Diseases | 1 | 2008 | 178 | 0.250 |
Why?
|
| Physical Endurance | 3 | 2020 | 48 | 0.240 |
Why?
|
| Female | 20 | 2024 | 34188 | 0.240 |
Why?
|
| Heart Diseases | 2 | 2019 | 223 | 0.240 |
Why?
|
| Pilot Projects | 6 | 2023 | 1021 | 0.240 |
Why?
|
| Smoking Cessation | 3 | 2019 | 553 | 0.230 |
Why?
|
| Cresols | 1 | 2024 | 5 | 0.220 |
Why?
|
| Sulfuric Acid Esters | 1 | 2024 | 5 | 0.220 |
Why?
|
| Indican | 1 | 2024 | 3 | 0.220 |
Why?
|
| Anaerobic Threshold | 1 | 2004 | 12 | 0.210 |
Why?
|
| Massachusetts | 5 | 2019 | 2153 | 0.210 |
Why?
|
| Feces | 1 | 2024 | 118 | 0.210 |
Why?
|
| Smoking | 2 | 2019 | 863 | 0.200 |
Why?
|
| Clinical Protocols | 1 | 2004 | 138 | 0.200 |
Why?
|
| Fear | 1 | 2023 | 71 | 0.190 |
Why?
|
| Coronary Disease | 1 | 2023 | 246 | 0.180 |
Why?
|
| Inflammation | 2 | 2020 | 1193 | 0.180 |
Why?
|
| Self Efficacy | 1 | 2023 | 205 | 0.180 |
Why?
|
| Dietary Supplements | 1 | 2024 | 236 | 0.180 |
Why?
|
| Muscle Strength | 2 | 2012 | 41 | 0.180 |
Why?
|
| Hospitalization | 2 | 2019 | 1399 | 0.180 |
Why?
|
| Cell-Free Nucleic Acids | 1 | 2021 | 14 | 0.180 |
Why?
|
| Healthy Lifestyle | 1 | 2021 | 28 | 0.170 |
Why?
|
| DNA, Mitochondrial | 1 | 2021 | 86 | 0.170 |
Why?
|
| Analysis of Variance | 2 | 2020 | 605 | 0.160 |
Why?
|
| Zea mays | 1 | 2020 | 32 | 0.160 |
Why?
|
| Treatment Outcome | 6 | 2021 | 5806 | 0.160 |
Why?
|
| Walking | 3 | 2017 | 246 | 0.160 |
Why?
|
| Adipokines | 1 | 2020 | 36 | 0.160 |
Why?
|
| Glomerular Filtration Rate | 2 | 2017 | 121 | 0.150 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2020 | 808 | 0.150 |
Why?
|
| Athletes | 2 | 2012 | 109 | 0.150 |
Why?
|
| Guidelines as Topic | 1 | 2019 | 158 | 0.140 |
Why?
|
| Running | 2 | 2012 | 83 | 0.130 |
Why?
|
| Health Promotion | 2 | 2019 | 523 | 0.130 |
Why?
|
| Accelerometry | 1 | 2018 | 64 | 0.130 |
Why?
|
| New England | 1 | 2018 | 271 | 0.130 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2011 | 83 | 0.130 |
Why?
|
| Young Adult | 3 | 2012 | 4834 | 0.130 |
Why?
|
| Surveys and Questionnaires | 3 | 2023 | 2776 | 0.130 |
Why?
|
| Physical Fitness | 2 | 2011 | 93 | 0.130 |
Why?
|
| Patient Compliance | 1 | 2019 | 370 | 0.120 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2017 | 47 | 0.120 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2019 | 271 | 0.120 |
Why?
|
| Adiposity | 2 | 2017 | 89 | 0.120 |
Why?
|
| Kidney Function Tests | 2 | 2012 | 36 | 0.120 |
Why?
|
| Decision Making | 1 | 2019 | 422 | 0.110 |
Why?
|
| Feasibility Studies | 2 | 2018 | 589 | 0.110 |
Why?
|
| Australia | 2 | 2025 | 130 | 0.110 |
Why?
|
| Kidney | 1 | 2017 | 454 | 0.100 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2018 | 504 | 0.100 |
Why?
|
| Circadian Rhythm | 1 | 2017 | 362 | 0.100 |
Why?
|
| Hypertension | 1 | 2019 | 616 | 0.100 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 2492 | 0.090 |
Why?
|
| Myocardial Infarction | 1 | 2019 | 921 | 0.090 |
Why?
|
| Cholesterol, LDL | 1 | 2012 | 104 | 0.090 |
Why?
|
| Monitoring, Ambulatory | 1 | 2012 | 56 | 0.090 |
Why?
|
| Football | 1 | 2012 | 17 | 0.090 |
Why?
|
| Prescriptions | 2 | 2022 | 33 | 0.090 |
Why?
|
| Waist Circumference | 1 | 2012 | 47 | 0.090 |
Why?
|
| Electromyography | 1 | 2012 | 99 | 0.090 |
Why?
|
| Factor Analysis, Statistical | 1 | 2012 | 102 | 0.090 |
Why?
|
| Diet, Reducing | 1 | 2011 | 27 | 0.090 |
Why?
|
| United States | 5 | 2025 | 8148 | 0.080 |
Why?
|
| Triglycerides | 1 | 2012 | 248 | 0.080 |
Why?
|
| Creatine Kinase | 1 | 2011 | 42 | 0.080 |
Why?
|
| Combined Modality Therapy | 1 | 2012 | 372 | 0.080 |
Why?
|
| Lactates | 1 | 2011 | 28 | 0.080 |
Why?
|
| Human Growth Hormone | 1 | 2011 | 18 | 0.080 |
Why?
|
| Vascular Diseases | 1 | 2011 | 83 | 0.080 |
Why?
|
| Reference Values | 1 | 2011 | 328 | 0.080 |
Why?
|
| Actinin | 1 | 2010 | 11 | 0.080 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2010 | 45 | 0.080 |
Why?
|
| Hydrocortisone | 1 | 2011 | 192 | 0.070 |
Why?
|
| Sports | 1 | 2010 | 98 | 0.070 |
Why?
|
| Adolescent | 2 | 2012 | 6329 | 0.070 |
Why?
|
| Energy Metabolism | 1 | 2011 | 399 | 0.070 |
Why?
|
| Body Mass Index | 1 | 2012 | 901 | 0.070 |
Why?
|
| Risk Factors | 1 | 2017 | 5459 | 0.060 |
Why?
|
| Brachial Artery | 1 | 2006 | 27 | 0.060 |
Why?
|
| Inpatients | 2 | 2019 | 322 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2021 | 1564 | 0.060 |
Why?
|
| Chronic Disease | 1 | 2008 | 743 | 0.060 |
Why?
|
| Yoga | 1 | 2004 | 15 | 0.050 |
Why?
|
| Endothelium, Vascular | 1 | 2006 | 177 | 0.050 |
Why?
|
| Renal Dialysis | 2 | 2004 | 191 | 0.050 |
Why?
|
| Cohort Studies | 1 | 2011 | 2632 | 0.050 |
Why?
|
| Muscles | 1 | 2004 | 179 | 0.050 |
Why?
|
| Consensus | 1 | 2024 | 178 | 0.050 |
Why?
|
| Obesity | 1 | 2011 | 1276 | 0.050 |
Why?
|
| Kidney Transplantation | 1 | 2006 | 325 | 0.050 |
Why?
|
| Hand Strength | 1 | 2002 | 34 | 0.050 |
Why?
|
| Pain | 1 | 2004 | 400 | 0.040 |
Why?
|
| Attitude | 1 | 2022 | 100 | 0.040 |
Why?
|
| Gait | 1 | 2002 | 121 | 0.040 |
Why?
|
| Inflammation Mediators | 1 | 2021 | 179 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2021 | 376 | 0.040 |
Why?
|
| Adiponectin | 1 | 2020 | 37 | 0.040 |
Why?
|
| Leptin | 1 | 2020 | 88 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2004 | 1710 | 0.040 |
Why?
|
| Pulse Wave Analysis | 1 | 2019 | 15 | 0.040 |
Why?
|
| Blood Pressure Determination | 1 | 2019 | 40 | 0.040 |
Why?
|
| Focus Groups | 1 | 2019 | 328 | 0.030 |
Why?
|
| Outpatients | 1 | 2019 | 143 | 0.030 |
Why?
|
| Intention | 1 | 2018 | 73 | 0.030 |
Why?
|
| F2-Isoprostanes | 1 | 2017 | 5 | 0.030 |
Why?
|
| Albuminuria | 1 | 2017 | 28 | 0.030 |
Why?
|
| Creatinine | 1 | 2017 | 136 | 0.030 |
Why?
|
| Pandemics | 1 | 2022 | 682 | 0.030 |
Why?
|
| Survival Rate | 1 | 2019 | 847 | 0.030 |
Why?
|
| Acute Disease | 1 | 2018 | 663 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2017 | 324 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2019 | 441 | 0.030 |
Why?
|
| Body Weight | 1 | 2017 | 376 | 0.030 |
Why?
|
| Counseling | 1 | 2018 | 376 | 0.030 |
Why?
|
| Anxiety | 1 | 2018 | 427 | 0.030 |
Why?
|
| Incidence | 1 | 2019 | 1429 | 0.030 |
Why?
|
| Research Design | 1 | 2018 | 590 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2010 | 1143 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2019 | 707 | 0.030 |
Why?
|
| Stress, Psychological | 1 | 2018 | 475 | 0.030 |
Why?
|
| Depression | 1 | 2018 | 903 | 0.020 |
Why?
|
| Fluoroimmunoassay | 1 | 2011 | 4 | 0.020 |
Why?
|
| Athletic Performance | 1 | 2011 | 7 | 0.020 |
Why?
|
| Jamaica | 1 | 2010 | 2 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2010 | 124 | 0.020 |
Why?
|
| Genotype | 1 | 2010 | 674 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2019 | 6926 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2011 | 2188 | 0.020 |
Why?
|
| Vasodilation | 1 | 2006 | 35 | 0.010 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2004 | 11 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2004 | 343 | 0.010 |
Why?
|
| Animals | 1 | 2011 | 21379 | 0.010 |
Why?
|